RedHill Biopharma (Israel) Probability of Target Price Finishing Over Current Price

RDHL -- Israel Stock  

ILS 308.40  12.00  4.05%

RedHill Biopharma probability of target price tool provides mechanism to make assumptions about upside and downside potential of RedHill Biopharma Ltd performance during a given time horizon utilizing its historical volatility. Please specify RedHill Biopharma time horizon, a valid symbol (red box) and a target price (blue box) you would like RedHill Biopharma odds to be computed. Additionally take a look at Your Equity Center.
Horizon     30 Days    Login   to change
Refresh Odds

RedHill Biopharma Target Price Odds to finish over

Current PriceHorizonTarget PriceOdds to move above current price in 30 days
 308.40 30 days 308.40  ABOUT 15.29%
Based on normal probability distribution, the odds of RedHill Biopharma to move above current price in 30 days from now is about 15.29% (This RedHill Biopharma Ltd probability density function shows the probability of RedHill Biopharma Stock to fall within a particular range of prices over 30 days) .
Assuming 30 trading days horizon, RedHill Biopharma Ltd has beta of -0.2364 . This implies as returns on benchmark increase, returns on holding RedHill Biopharma are expected to decrease at a much smaller rate. During bear market, however, RedHill Biopharma Ltd is likely to outperform the market. Additionally RedHill Biopharma Ltd has an alpha of 0.7162 implying that it can potentially generate 0.7162% excess return over DOW after adjusting for the inherited market risk (beta).
 RedHill Biopharma Price Density 
Current Price   Target Price   
Alpha over DOW
Beta against DOW=0.24
Overall volatility
Information ratio =0.21

RedHill Biopharma Alerts

RedHill Biopharma Alerts and Suggestions

RedHill Biopharma is not yet fully synchronised with the market data
RedHill Biopharma appears to be very risky and stock price may revert if volatility continues
The company reported revenue of 6.45 M. Net Loss for the year was (46.88 M) with profit before overhead, payroll, taxes, and interest of 1.88 M.
REDHILL BIOPHARMA has accumulated about 36.35 M in cash with (43.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.17.
Latest headline from RedHill Biopharma Ltd. s Volatility Moves the Target Weight to 0.02130 With 13.26930 Sales Growth
Additionally take a look at Your Equity Center. Please also try Transaction History module to view history of all your transactions and understand their impact on performance.